SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Scholar Rock Holding Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$40.24+0.34 (+0.85%)
Close on Oct 19, 2026
- Market cap
- $5.26B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$12.30 (+44.02%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Scholar Rock Holding Corp reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$297.01M.
Revenue
$0
TTM Q2 2026
Operating income
-$406.36M
TTM Q2 2026
Free cash flow
-$297.01M
TTM Q2 2026
EPS, diluted
-$3.32
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.26B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 20.71
- Dividend yield
- –
- Free cash flow yield
- -5.65%
Fundamentals
- Revenue
- $0
- Net income
- -$408.59M
- EPS, diluted
- -$3.32
- Free cash flow
- -$297.01M
- Book value per share
- $1.94
- Diluted shares
- 131M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$0
Operating income
-$406.36M
Net income
-$408.59M
EPS, diluted
-$3.32
Free cash flow
-$297.01M
Reported periodTrailing twelve months